WEBINAR: Cancer-Induced Peripheral Neuropathy: How to Manage Symptoms

Some reports show that approximately 60 to 70% of patients who receive chemotherapy develop Chemotherapy-Induced Peripheral Neuropathy. In some survivors, the damage is prevalent after chemotherapy has been completed. Do you or a loved one suffer from Cancer-Induced Peripheral Neuropathy? Is it interfering with your daily life?
In this webinar from MD Anderson Cancer Center a Cooper (New Jersey), Samuel Hardy, MD discusses the following:
· What is Cancer-Induced Peripheral Neuropathy?
· What can you do to reduce your risk factors?
· What are the signs and symptoms?
· How is it diagnosed?
· What are the latest treatments for Cancer-Induced Peripheral Neuropathy?
About the Presenter:
Dr. Samuel Hardy is the Head of the Division of Palliative Medicine and Program Director of the Hospice and Palliative Medicine Fellowship. He specializes in symptom management for oncology patients, malignant bone pain, and cancer anorexia/cachexia.
To learn more about cancer services at MD Anderson at Cooper, visit www.cooperheal...
This webinar was recorded on May 6, 2022.